Search

everythinglearnresearchcommunity

for

Search:↓

Accurate early diagnosis of Lichen Planopilaris is crucial to prevent permanent hair loss.

Ayurvedic treatments can improve symptoms and quality of life for systemic sclerosis patients.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

ANA-negative lupus nephritis can be diagnosed and treated effectively with a comprehensive approach.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

Using a special skin cream with gabapentin helped reduce symptoms of a certain scalp condition but didn't change nerve fibers or skin chemicals.

A woman's hair loss was misdiagnosed as alopecia areata but was actually lichen planopilaris, needing immediate and ongoing treatment.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

Nanocarriers with plant extracts show promise for safe and effective hair growth treatment.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Certain hairstyles, diabetes, scalp infections, and vitamin D deficiency may increase the risk of hair loss in Black women; more research is needed for better treatment.

About 61% of women who had COVID-19 experienced hair loss afterward.

Non-adherence to medication in Egyptian SLE patients leads to more hospitalizations and symptoms.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

Early diagnosis and aggressive treatment are crucial for managing SLE-related pancreatitis in children.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

New understanding and treatments for hair loss are improving, but more research is needed.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.